Clinical Trials Insight: 700031614
Phase of Trial: Phase III
Latest Information Update: 07 Apr 2008
At a glance
- Drugs Creatine monohydrate (Primary)
- Indications Huntington's disease
- Focus Registrational; Therapeutic Use
- Sponsors Avicena Group
- 07 Apr 2008 Enrolment is expected to be initiated in the third quater of 2008.
- 17 Mar 2008 New trial record.